SCOR SE

ENXTPA:SCR Voorraadrapport

Marktkapitalisatie: €5.7b

SCOR Toekomstige groei

Future criteriumcontroles 0/6

De winst van SCOR zal naar verwachting dalen met 3.2% per jaar, terwijl de jaarlijkse omzet naar verwachting zal groeien met 1.6% per jaar. De winst per aandeel zal naar verwachting dalen met 2.9% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 14.1% zijn.

Belangrijke informatie

-3.2%

Groei van de winst

-2.91%

Groei van de winst per aandeel

Insurance winstgroei5.5%
Inkomstengroei1.6%
Toekomstig rendement op eigen vermogen14.08%
Dekking van analisten

Good

Laatst bijgewerkt21 May 2026

Recente toekomstige groei-updates

Recent updates

Narratiefupdate • May 15

SCR: Rising Street Confidence And Dividend Policy Will Shape Future Balance

SCOR's updated analyst price target edges up from €33.00 to about €33.86, reflecting analysts' recent target increases at several banks. These increases point to slightly higher fair value and P/E assumptions, despite more cautious revenue growth inputs.
Narratiefupdate • Apr 20

SCR: Higher Street Expectations And Dividend Plans Will Shape Future Balance

SCOR's updated analyst price target edges higher to about €33, supported by recent Street research that has moved targets into a €34 to €38 range as analysts refine assumptions around discount rate, profit margin and future P/E. Analyst Commentary Recent Street research on SCOR has centered on higher price targets, with several bullish analysts revisiting their assumptions on discount rates, profitability and acceptable P/E levels for the stock.
Narratiefupdate • Apr 05

SCR: Mixed Rating Shifts And New CFO Appointment Will Shape Future Balance

The analyst price target for SCOR has been revised slightly higher, with the fair value estimate moving from approximately €32.74 to about €33.01. This adjustment is supported by a series of recent target increases from banks such as Berenberg, Morgan Stanley and Citi, along with an upgrade at BNP Paribas.
Narratiefupdate • Mar 22

SCR: Mixed Rating Shifts And New CFO Appointment Will Shape Balanced Outlook

SCOR's updated analyst price target edges higher to €32.74 from €31.98, with analysts citing refreshed models that reflect revised growth and margin assumptions, a modestly higher future P/E multiple, and a series of recent target increases from major banks. Analyst Commentary Recent research updates point to a mixed but generally constructive stance on SCOR, with several price target revisions clustered in the low to mid €30s and one higher target in the high €30s.
Narratiefupdate • Mar 07

SCR: Mixed Rating Shifts And New CFO Appointment Shape Balanced Outlook

Analysts have lifted their implied price target on SCOR from about €31.74 to roughly €32, pointing to a slightly higher fair value as they factor in updated growth assumptions and recent target hikes from several banks alongside one downgrade. Analyst Commentary Recent research updates on SCOR reflect a mixed but generally constructive tone, with several firms lifting price targets while one high profile bank has turned more cautious.
Narratiefupdate • Feb 20

SCR: Balanced Outlook As Execution And New CFO Transition Guide Rerating Potential

Analysts have nudged their price target on SCOR higher to €32. The modest change reflects a mix of recent target increases, such as Berenberg's €1.50 uplift, and offsetting caution from other firms, all incorporated into updated valuation assumptions.
Narratiefupdate • Feb 06

SCR: Execution On Earnings And New CFO Appointment Will Shape Rerating Potential

Analysts have trimmed their price target on SCOR from €32.00 to about €31.74, reflecting slightly lower fair value and profit margin assumptions alongside modestly reduced future P/E expectations. Analyst Commentary Bullish Takeaways Bullish analysts highlight the recent upgrade to Outperform as a sign that current valuation is seen as reasonable relative to their €32 price target.
Narratiefupdate • Jan 22

SCR: Reinsurance Execution And Earnings Quality Will Support Future Rerating

Analysts have inched their average price target for SCOR up to about €32, with small adjustments to discount rate, revenue growth, profit margin and future P/E, reflecting a more finely balanced view after recent rating changes and price target updates across the Street. Analyst Commentary Recent Street research on SCOR has sent mixed signals, with changes in ratings and modest adjustments to price targets clustering around the low €30s.
Narratiefupdate • Jan 08

SCR: Reinsurance Pricing And Margin Discipline Will Support Future Rerating

Narrative Update: Analyst Price Targets for SCOR Analysts now see SCOR's price target clustered in the low to mid €30s, with recent updates ranging from about €31.76 to €35 as they adjust their views using broadly consistent assumptions for fair value, discount rate, revenue growth, profit margin and future P/E. Analyst Commentary Recent target changes for SCOR cluster between about €31.76 and €35.
Narratiefupdate • Dec 22

SCR: Rising Reinsurance Pricing And Margin Discipline Will Support Future Upside

The analyst price target for SCOR has edged higher to EUR 31.76 from EUR 31.98, as analysts factor in a slightly lower discount rate, marginally improved profit margin expectations, and supportive upward target revisions from major brokerage houses. Analyst Commentary Recent Street research reflects a generally constructive stance on SCOR, with multiple upward revisions to price targets alongside one modest downgrade.
Narratiefupdate • Dec 08

SCR: Rising Reinsurance Pricing And Margin Discipline Will Drive Future Performance

Analysts have nudged their average price target on SCOR slightly lower to about EUR 31.76 from roughly EUR 31.98. This reflects modestly higher discount rate assumptions even as they remain broadly constructive on the shares.
Narratiefupdate • Nov 24

SCR: Recent Margin Gains And Improved Outlook Will Drive Future Performance

SCOR's analyst price target has increased modestly from €31.24 to €31.98. Analysts cite slight improvements in profit margin expectations and a supportive outlook from recent Street research as key factors behind the revision.
Narratiefupdate • Nov 05

SCR: Improved Margins And Upward Revisions Will Drive Future Share Outperformance

The analyst consensus price target for SCOR fell slightly from €31.998 to €31.244, as analysts cited modestly lower revenue growth projections. This was balanced against improved profit margins and valuation multiples.
Narratiefupdate • Oct 22

Analyst Commentary Highlights Rising Confidence in SCOR Amid Upward Revisions and Improved Valuation Metrics

SCOR's analyst price target has increased from €31.36 to €31.99. This change reflects recent analyst confidence in improved profit margins and revenue growth forecasts.
Analyseartikel • Oct 15

Investors Holding Back On SCOR SE (EPA:SCR)

SCOR SE's ( EPA:SCR ) price-to-earnings (or "P/E") ratio of 10.3x might make it look like a buy right now compared to...
Narratiefupdate • Oct 08

Elevated Climate Risk And Diversification Will Unlock Reinsurance Value

Analysts have modestly increased their price target for SCOR from $30.81 to $31.36. They cite improved profit margin expectations and a lower discount rate as key factors supporting the upward revision.
User avatar
Nieuw narratief • Dec 15

Forward 2026 And Decisive P&C Initiatives Poised To Restore Profitability And Boost Earnings

Successful strategic plan and assumption reviews could restore profitability and stabilize future returns through improved business strategies.

Winst- en omzetgroeiprognoses

ENXTPA:SCR - Toekomstschattingen van analisten en financiële gegevens uit het verleden (EUR Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/202818,7287942,1651,6512
12/31/202718,0827842,1161,2932
12/31/202617,4147652,0692,0692
3/31/202615,4778761,1231,168N/A
12/31/202515,6898511,1301,169N/A
9/30/202516,1598751,1571,202N/A
6/30/202516,1515411,1191,163N/A
3/31/202516,3408874902N/A
12/31/202416,4604875903N/A
9/30/202415,593-671,2911,294N/A
6/30/202415,0801981,5261,529N/A
3/31/202416,3536971,3311,350N/A
12/31/202316,2428121,4471,480N/A
9/30/202320,0651,3761,2911,338N/A
6/30/202315,869-6061,0481,105N/A
3/31/202319,56345831897N/A
12/31/202215,984-1,383430500N/A
9/30/202216,791-910371442N/A
6/30/202217,180-1991,4341,507N/A
3/31/202217,8103311,7011,776N/A
1/1/202217,6754562,3192,406N/A
9/30/202116,3734382,2392,345N/A
6/30/202116,8905881,0611,176N/A
3/31/202116,8341171,1271,256N/A
12/31/202016,973234853988N/A
9/30/202016,938156796929N/A
6/30/202016,9521621,0111,151N/A
3/31/202016,818453833970N/A
12/31/201916,546422N/A841N/A
9/30/201916,157381N/A653N/A
6/30/201916,114346N/A671N/A
3/31/201915,762287N/A885N/A
12/31/201815,639322N/A891N/A
9/30/201815,404603N/A1,284N/A
6/30/201815,340256N/A1,069N/A
3/31/201815,339312N/A1,245N/A
12/31/201715,334286N/A1,144N/A
9/30/201715,126190N/A721N/A
6/30/201715,036620N/A1,232N/A
3/31/201714,715573N/A1,059N/A
12/31/201614,369603N/A1,354N/A
9/30/201614,251588N/A1,541N/A
6/30/201614,191590N/A1,115N/A
3/31/201614,089637N/A1,050N/A
12/31/201513,930642N/A795N/A
9/30/201513,296627N/A982N/A
6/30/201512,874583N/A1,022N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De winst van SCR zal naar verwachting de komende 3 jaar dalen ( -3.2% per jaar).

Winst versus markt: De winst van SCR zal naar verwachting de komende 3 jaar dalen ( -3.2% per jaar).

Hoge groeiwinsten: De winst van SCR zal naar verwachting de komende 3 jaar dalen.

Omzet versus markt: De omzet van SCR ( 1.6% per jaar) zal naar verwachting langzamer groeien dan de markt French ( 5.6% per jaar).

Hoge groei-inkomsten: De omzet van SCR ( 1.6% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen SCR zal naar verwachting over 3 jaar laag zijn ( 14.1 %).

Ontdek groeibedrijven

7D

1Y

7D

1Y

7D

1Y

Bedrijfsanalyse en status van financiële gegevens

GegevensLaatst bijgewerkt (UTC-tijd)
Bedrijfsanalyse2026/05/21 10:35
Aandelenkoers aan het einde van de dag2026/05/21 00:00
Inkomsten2026/03/31
Jaarlijkse inkomsten2025/12/31

Gegevensbronnen

De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.

PakketGegevensTijdframeVoorbeeld Amerikaanse bron *
Financiële gegevens bedrijf10 jaar
  • Resultatenrekening
  • Kasstroomoverzicht
  • Balans
Consensus schattingen analisten+3 jaar
  • Financiële prognoses
  • Koersdoelen analisten
Marktprijzen30 jaar
  • Aandelenprijzen
  • Dividenden, splitsingen en acties
Eigendom10 jaar
  • Top aandeelhouders
  • Handel met voorkennis
Beheer10 jaar
  • Leiderschapsteam
  • Raad van bestuur
Belangrijkste ontwikkelingen10 jaar
  • Bedrijfsaankondigingen

* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.

Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.

Analysemodel en Snowflake

Details van het analysemodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina. We hebben ook handleidingen over hoe je onze rapporten kunt gebruiken en tutorials op YouTube.

Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.

Industrie en sector

Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.

Bronnen van analisten

SCOR SE wordt gevolgd door 31 analisten. 11 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.

AnalistInstelling
Daniel BischofBaader Helvea Equity Research
Ivan BokhmatBarclays
Michael HuttnerBerenberg